EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment

Elixabet Bolaños iD, Lorena Cañas-Zabala iD, Irene Olivera iD, David Ruiz Guillamón iD, Enric Vercher iD, Gabriel Gomis iD, Carlos E de Andrea iD, Raluca Alexandru iD, Arantza Azpilikueta iD, Nekane Soria iD, Dayanna Salinas iD, Paula Molero-Glez iD und 10 weitere

Journal of Experimental Medicine · 05.10.2026 · 223 (10)

DOI: 10.1084/jem.20252080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 07.09.2026. Verfasst von Elixabet Bolaños und 21 weiteren Autor:innen. Beteiligte Einrichtung: Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Cancer Center, Clínica Universidad de Navarra (CCUN) , Pamplona, Spain. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Tumor Microenvironment, Tumor Escape, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Innovation and Universities, Agencia Estatal de Investigación, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TNFα is a proinflammatory cytokine that can mediate immunosuppressive effects in cancer. Tumors in which we silenced TNFR1 by CRISPR/Cas9 showed that TNFR1KO variants poorly engrafted in immunocompetent hosts, while engraftment in immunodeficient or CD8 T lymphocyte–depleted mice was preserved. The mechanism was mediated by secondary chemotactic inflammatory mediators elicited by TNFα in the malignant cells themselves. As a result, TNFR1KO variants recruited drastically fewer myeloid-derived suppressor cells (MDSCs) into the tumor microenvironment, thus explaining the immune escape of the WT variants. Interestingly, small amounts of TNFR1-sufficient tumor cells co-engrafted with the TNFR1KO variants rescued tumorigenicity in the same tumor lesion but not in distantly implanted TNFR1KO tumors. Secondary mediators chiefly include CXCR1/2-acting chemokines, prostaglandin E2 and TNFα itself. Knocking down TNFR1 in a human tumor cell line rendered comparable MDSC-recruiting results when xenografted. Analyses of scRNA-seq and spatial transcriptomics datasets from human solid tumors corroborate the role of TNFR1 on tumor cells in the induction of secondary pro-tumor inflammatory mediators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Type ITumor MicroenvironmentTumor EscapeNeoplasmsAnimalsHumansMiceTumor Necrosis Factor-alphaCell Line, TumorMyeloid-Derived Suppressor CellsMice, Knockout

Substanzen

Receptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alphaTnfrsf1a protein, mouse

Autor:innen und Institutionen

  • Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Cancer Center, Clínica Universidad de Navarra (CCUN) , Pamplona, Spain.
  • Navarra Institute for Health Research (IDISNA) , Pamplona, Spain.
  • Department of Pathology, Anatomy and Physiology, Clinica Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), University of Navarra, Pamplona, Spain.
  • Department of Immunology and Immunotherapy, Clinica University of Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) , Madrid, Spain.
  • Unité Mixte de Recherche INSERM 1037, CNRS 5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT) , Toulouse, France.

ORCID-Profile: Elixabet Bolaños, Lorena Cañas-Zabala, Irene Olivera, David Ruiz Guillamón, Enric Vercher, Gabriel Gomis, Carlos E de Andrea, Raluca Alexandru, Arantza Azpilikueta, Nekane Soria, Dayanna Salinas, Paula Molero-Glez, Carlos Luri-Rey, Saioa Arrieta-Aranzueque, Almudena Manzanal, Mario Garcia-Dominguez, Diego Alignani, Bruno Ségui, Angie Molina, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero

Förderung

  • Ministry of Science, Innovation and Universities
  • Agencia Estatal de Investigación
  • Instituto de Salud Carlos III
  • European Union - NextGenerationEU
  • Fundación Científica Asociación Española Contra el Cáncer
  • "La Caixa" Foundation
  • European Research Council
  • FERO Foundation

Zitieren

APA

Bolaños, E., Cañas-Zabala, L., Olivera, I., Ruiz Guillamón, D., Vercher, E., Gomis, G., de Andrea, C. E., Alexandru, R., Azpilikueta, A., Soria, N., Salinas, D., Molero-Glez, P., Luri-Rey, C., Arrieta-Aranzueque, S., Manzanal, A., Garcia-Dominguez, M., Alignani, D., Ségui, B., Molina, A., …, & Melero, I. (2026). TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. Journal of Experimental Medicine, 223(10). https://doi.org/10.1084/jem.20252080

Vancouver

Bolaños E, Cañas-Zabala L, Olivera I, Ruiz Guillamón D, Vercher E, Gomis G, et al. TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. Journal of Experimental Medicine. 2026;223(10). doi:10.1084/jem.20252080

BibTeX
@article{Bolaos2026,
  author = {Bolaños, Elixabet and Cañas-Zabala, Lorena and Olivera, Irene and Ruiz Guillamón, David and Vercher, Enric and Gomis, Gabriel and de Andrea, Carlos E and Alexandru, Raluca and Azpilikueta, Arantza and Soria, Nekane and Salinas, Dayanna and Molero-Glez, Paula and Luri-Rey, Carlos and Arrieta-Aranzueque, Saioa and Manzanal, Almudena and Garcia-Dominguez, Mario and Alignani, Diego and Ségui, Bruno and Molina, Angie and Teijeira, Álvaro and Berraondo, Pedro and Melero, Ignacio},
  title = {TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {10},
  doi = {10.1084/jem.20252080}
}
Kostenlos starten →